ComparisonAugust 6, 2026 · 1 min read

GHK-Cu vs BPC-157: Copper Peptide vs Pentadecapeptide

Research compounds for laboratory use only · not medical advice

Two tissue-focused peptides from different worlds — copper complex vs gastric pentadecapeptide, 50 mg vs 5 mg vial, and how each is studied.

Both GHK-Cu and BPC-157 get filed under “tissue repair” in researchers’ notes, but they are about as different as two small peptides can be — different size, different metal content, different research footprint.

Two molecules, two worlds

Property GHK-Cu BPC-157
Identity Copper tripeptide-1 (GHK + Cu) Gastric pentadecapeptide
Molecular weight ≈ 404 g/mol ≈ 1,419 g/mol
Vial size 50 mg lyophilized 5 mg lyophilized
Research focus Fibroblast, collagen, wound-repair models Angiogenesis, tendon, GI mucosa models

GHK-Cu is three amino acids wrapped around a copper ion — the copper is part of what’s being studied, not an impurity. BPC-157 is a fifteen-amino-acid peptide first isolated from gastric juice, with a research footprint in angiogenesis and mucosal stability. The BPC-157 vs TB-500 guide covers the other side of the repair-peptide family.

The vial-size difference is deliberate

Protocols treat these two on different scales, which is why the vials differ tenfold:

  • GHK-Cu 50 mg in 2 mL → 25,000 µg/mL. A 1,000 µg dose is 40 µL (4 units).
  • BPC-157 5 mg in 2 mL → 2,500 µg/mL. A 250 µg dose is 10 units.

The reconstitution calculator carries both presets, and the molecular weight calculator helps when protocols switch to molar units.

Practical notes

Both are lyophilized at −20 °C and reconstituted with USP bacteriostatic water. GHK-Cu solutions can take on a faint blue tint at higher concentrations — a property of the copper, not a degradation sign. Full specs: GHK-Cu and BPC-157.

For laboratory research use only. Not medical advice.

Last updated September 9, 2026

FAQ

Frequently asked questions

What is the key difference?

GHK-Cu is a copper tripeptide complex (≈ 404 g/mol) studied in fibroblast and collagen pathways. BPC-157 is a gastric pentadecapeptide (≈ 1,419 g/mol) studied in angiogenesis and mucosal models.

The vials are very different sizes — why?

GHK-Cu ships at 50 mg and BPC-157 at 5 mg. Research protocols dose them on very different scales, so the vial sizes follow the typical working concentrations.

Can they be reconstituted the same way?

The math is identical (mass ÷ volume), but the numbers differ: 50 mg in 2 mL gives 25,000 µg/mL, while 5 mg in 2 mL gives 2,500 µg/mL. The calculator has presets for both.